November 09, 2022
The director of translational research in myeloma at the Tisch Cancer Institute discussed the relevance of the new research as more CAR T therapies come to market.
October 17, 2022
The director of translational research in myeloma at the Tisch Cancer Institute discussed positive findings, including a 30-month PFS in study participants.
October 07, 2022
The director of translational research in myeloma at the Tisch Cancer Institute discussed investigating sequential T cell redirection therapies.